Role of adenosine signaling in the pathogenesis of head and neck cancer. Issue 10 (16th July 2018)

• Record Type: Journal Article
• Authors: Khayami, Reza; Toroghian, Younes; Bahreyni, Amirhossein; Bahrami, Afsane; Khazaei, Majid; Ferns, Gordon A.; Ebrahimi, Safieh; Soleimani, Anvar; Fiuji, Hamid; Avan, Amir; Hassanian, Seyed Mahdi
• Is Part Of: Journal of cellular biochemistry. Volume 119:Issue 10(2018)
• Page Start: 7905
• Page End: 7912
• Publication Date: 2018-07-16
• Subjects: adenosine -- adenosine‐generating enzymes -- adenosine receptors -- head and neck cancer; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.27091
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: The concentrations of adenosine may increase under ischemic conditions in the tumor microenvironment, and then it enters the systemic circulation. Adenosine controls cancer progression and responses to therapy by regulating angiogenesis, cell survival, apoptosis, cell proliferation, and metastases in tumors. Hence, adenosine metabolism, adenosine‐generating enzymes, and adenosine signaling are potentially novel therapeutic targets in a wide range of pathological conditions, including cerebral and cardiac ischemic diseases, inflammatory disorders, immunomodulatory disorders, and, of special interest in this review, cancer. This review summarizes the role of adenosine in the pathogenesis of head and neck cancer for a better understanding of how this may be applied to treating this type of cancer. Abstract : Adenosine metabolism, adenosine‐generating enzymes, and adenosine signaling are potentially novel therapeutic targets in a wide range of pathological conditions, including cerebral and cardiac ischemic diseases, inflammatory disorders, immunomodulatory disorders, and, of special interest in this review, cancer. This review summarizes the role of adenosine in the pathogenesis of head and neck cancer for a better understanding of how this may be applied to treating this type of cancer.